Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q2 2019 · 10-Q
Revenue$0.00$0.00−100.0% vs Q2 2018 Net Income-$402.50K-$402.50KN/M vs Q2 2018 EPS Diluted$0.00$0.00— vs Q2 2018 Operating Income-$335,243N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$230,423N/M ended Jun 30, 2019 · filed Aug 12, 2019 · 43 d after period end